Mednet Logo
CommunityPulmonology

Do you integrate inhaled colistimethate sodium into existing treatment regimens for patients with bronchiectasis and PSAR infection?

PROMIS-I and II
2 Answers
Mednet Member
Mednet MemberInvited Expert
Pulmonology · Tulane University School of Medicine
Answered on

I agree with Dr. @Dr. First Last. I also consider inhaled colistimethate sodium in addition to tobramycin and aztreonam when developing treatment regimens.

Of note, while the inhaled route of antibiotics can decrease the risk of side effects in other parts of the body (nephrotoxicity, ototoxicity, e...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Pulmonology · University of California (San Diego) Medical Center
Answered on · Updated on

Yes, I do integrate inhaled colistimethate sodium despite the conflicting data in the PROMIS-I and II trials. Anecdotally, I have had as much success with inhaled colistimethate as with inhaled aztreonam and inhaled tobramycin, the data for which is not robust either. I consider any of these drugs i...

Join for free or sign in to see the full answer